News Focus
News Focus
Followers 245
Posts 13889
Boards Moderated 0
Alias Born 05/19/2015

Re: 29YEARINVESTOR post# 110774

Wednesday, 07/27/2022 8:22:46 AM

Wednesday, July 27, 2022 8:22:46 AM

Post# of 118616
Yep! Links with proof WiLL always prove Them Fudpucker naked short and distort MM’s and there crony Twitter bashers Continuous Fud Wrong!
Boom! Mic Drop!
In 2021 the Company was granted US patent # 11,090,332 on composition of matter of survivin modified-mRNA useful for teaching the immune system to kill cancer. In the current patent, specific types of dendritic cells, means of generating specialized dendritic cells, and the planned formulation that will enter clinical trials have been granted patent protection.
https://www.prnewswire.com/news-releases/regen-biopharma-inc--files-provisional-patent--application-on-second-generation-survivin-mrna-cancer-immunotherapy-vaccine-301593795.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y